Researchers at Örebro University in Sweden have made a groundbreaking discovery in the field of inflammatory bowel disease (IBD). Their study has identified specific protein patterns in the blood that can predict the onset of IBD, including Crohn's disease and ulcerative colitis, years before
A promising new approach in battling Alzheimer's disease has emerged, involving an innovative nasal spray drug that targets a specific brain enzyme. Researchers at Università Cattolica and Fondazione Policlinico Universitario A. Gemelli IRCCS have discovered that inhibiting the enzyme
In a significant development for cardiovascular medicine, BridgeBio's Attruby (acoramidis) has received FDA approval for treating Transthyretin amyloid cardiomyopathy (ATTR-CM) in adults, marking a crucial milestone for a rare and severe heart condition that can lead to fatal outcomes if left
Schizophrenia is a severe mental health disorder that ranks as one of the leading causes of disability worldwide, significantly impacting memory, attention, and executive function. Despite the profound challenges it presents, there are currently no approved treatments for cognitive impairment
In a bold move to tackle one of the most formidable cancers, Anocca AB has announced the submission of a Clinical Trial Application (CTA) to the European Medicines Agency (EMA) for their innovative VIDAR-1 Phase I/II multi-asset trial, targeting advanced pancreatic cancer. The pioneering trial, set
The University of Southern California (USC) has entered into a groundbreaking partnership with Autobahn Labs to speed up early-stage drug discovery, marking a transformative step in translating academic research into effective treatments. This collaboration aims to leverage USC's vast scientific
